Fangzhou Ye

930 total citations
23 papers, 341 citations indexed

About

Fangzhou Ye is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Fangzhou Ye has authored 23 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Fangzhou Ye's work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (5 papers). Fangzhou Ye is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (5 papers). Fangzhou Ye collaborates with scholars based in China, United States and Macao. Fangzhou Ye's co-authors include Yiran Liang, Qifeng Yang, Yajie Wang, Bing Chen, Dianwen Han, Yaming Li, Wenjing Zhao, Lijuan Wang, Yuhan Jin and Xiaoli Kong and has published in prestigious journals such as Oncogene, British Journal of Cancer and Molecular Cancer.

In The Last Decade

Fangzhou Ye

23 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangzhou Ye China 9 174 133 102 77 49 23 341
Jiwei Xu China 8 253 1.5× 193 1.5× 154 1.5× 66 0.9× 48 1.0× 22 415
Johan Swinnen Belgium 7 131 0.8× 107 0.8× 99 1.0× 47 0.6× 38 0.8× 16 330
Xianli He China 10 242 1.4× 143 1.1× 96 0.9× 142 1.8× 37 0.8× 19 469
Yirui Yin China 11 206 1.2× 136 1.0× 84 0.8× 78 1.0× 34 0.7× 23 343
Ram C. Shankaraiah Italy 10 188 1.1× 147 1.1× 56 0.5× 95 1.2× 42 0.9× 11 339
Jingsheng Yuan China 11 256 1.5× 203 1.5× 100 1.0× 57 0.7× 22 0.4× 26 365
Yixiao Xiong China 12 233 1.3× 144 1.1× 112 1.1× 62 0.8× 33 0.7× 20 405
Atsutaka Masuda Japan 9 142 0.8× 92 0.7× 51 0.5× 85 1.1× 32 0.7× 19 279
Canrong Lu China 13 207 1.2× 138 1.0× 86 0.8× 114 1.5× 42 0.9× 22 368
Haigang Geng China 7 140 0.8× 74 0.6× 75 0.7× 72 0.9× 24 0.5× 20 311

Countries citing papers authored by Fangzhou Ye

Since Specialization
Citations

This map shows the geographic impact of Fangzhou Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangzhou Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangzhou Ye more than expected).

Fields of papers citing papers by Fangzhou Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangzhou Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangzhou Ye. The network helps show where Fangzhou Ye may publish in the future.

Co-authorship network of co-authors of Fangzhou Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Fangzhou Ye. A scholar is included among the top collaborators of Fangzhou Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangzhou Ye. Fangzhou Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liang, Yiran, Bing Chen, Long Li, et al.. (2024). LncRNA PRBC induces autophagy to promote breast cancer progression through modulating PABPC1-mediated mRNA stabilization. Oncogene. 43(14). 1019–1032. 6 indexed citations
3.
Zhang, Yaqiong, Jian Li, Zhe Qin, et al.. (2024). METTL5 promotes gastric cancer progression via sphingomyelin metabolism. World Journal of Gastrointestinal Oncology. 16(5). 1925–1946. 2 indexed citations
4.
Li, Long, Lei Wang, Yiran Liang, et al.. (2024). UGCG promotes chemoresistance and breast cancer progression via NF-κB and Wnt/β-catenin pathway activation. Translational Oncology. 52. 102241–102241. 2 indexed citations
5.
Liang, Yiran, Fangzhou Ye, Li Long, et al.. (2024). Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer. Molecular Cancer. 23(1). 125–125. 20 indexed citations
6.
Liang, Yiran, Yajie Wang, Yan Zhang, et al.. (2023). HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer. Cell Death and Disease. 14(7). 434–434. 62 indexed citations
7.
Ye, Fangzhou, Yiran Liang, Yajie Wang, et al.. (2023). Cancer-associated fibroblasts facilitate breast cancer progression through exosomal circTBPL1-mediated intercellular communication. Cell Death and Disease. 14(7). 471–471. 37 indexed citations
8.
Luo, Dan, Yiran Liang, Yajie Wang, et al.. (2023). Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD. Breast Cancer Research. 25(1). 115–138. 5 indexed citations
9.
Wang, Yajie, Yiran Liang, Fangzhou Ye, et al.. (2023). Histologic heterogeneity predicts patient prognosis of HER2‐positive metastatic breast cancer: A retrospective study based on SEER database. Cancer Medicine. 12(18). 18597–18610. 4 indexed citations
10.
Ye, Fangzhou, et al.. (2023). Design and Verification of Online Dialogue Promoting Deep Learning Supported by Intelligent Technology. 10. 1304–1309. 1 indexed citations
11.
Ye, Fangzhou, Liangkai Chen, & Xin Zheng. (2023). Diabetes and the risk of cirrhosis and HCC: An analysis of the UK Biobank. Hepatology Communications. 7(11). 3 indexed citations
12.
Li, Jian, Yaqiong Zhang, Fangzhou Ye, et al.. (2023). DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway. Cancers. 15(19). 4756–4756. 9 indexed citations
13.
Song, Xiaojin, Bing Chen, Yiran Liang, et al.. (2022). CircEIF3H-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1/RBM8A/G3BP1 mRNA. Cell Death Discovery. 8(1). 261–261. 14 indexed citations
14.
Zhang, Yan, Yiran Liang, Yajie Wang, et al.. (2022). A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer. International Journal of Oncology. 61(6). 5 indexed citations
15.
Ye, Fangzhou, et al.. (2021). Jane Street Stock prediction model based on LightGBM. 385–388. 5 indexed citations
16.
Liang, Yiran, Fangzhou Ye, Yajie Wang, et al.. (2021). DGUOK-AS1 acts as a tumor promoter through regulating miR-204-5p/IL-11 axis in breast cancer. Molecular Therapy — Nucleic Acids. 26. 1079–1091. 13 indexed citations
17.
Wang, Yajie, Fangzhou Ye, Yiran Liang, & Qifeng Yang. (2021). Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies. British Journal of Cancer. 125(8). 1056–1067. 77 indexed citations
18.
Fan, Junming, Xiaofang Fan, Fangzhou Ye, et al.. (2020). Upregulation of miR-335-3p by NF-κB Transcriptional Regulation Contributes to the Induction of Pulmonary Arterial Hypertension via APJ during Hypoxia. International Journal of Biological Sciences. 16(3). 515–528. 25 indexed citations
19.
Ye, Fangzhou, Wen‐Yue Liu, Kenneth I. Zheng, et al.. (2019). Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology. 32(1). 80–86. 8 indexed citations
20.
Zhou, Yujie, Fangzhou Ye, Yangyang Li, et al.. (2019). Individualized risk prediction of significant fibrosis in non‐alcoholic fatty liver disease using a novel nomogram. United European Gastroenterology Journal. 7(8). 1124–1134. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiwei Xu Breakdown of academic impact, for papers by Johan Swinnen Breakdown of academic impact, for papers by Xianli He Breakdown of academic impact, for papers by Yirui Yin Breakdown of academic impact, for papers by Ram C. Shankaraiah Breakdown of academic impact, for papers by Jingsheng Yuan Breakdown of academic impact, for papers by Yixiao Xiong Breakdown of academic impact, for papers by Atsutaka Masuda Breakdown of academic impact, for papers by Canrong Lu Breakdown of academic impact, for papers by Haigang Geng
Rankless by CCL
2026